Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CELECOXIB Cause Wrong technique in product usage process? 80 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 80 reports of Wrong technique in product usage process have been filed in association with CELECOXIB (Celecoxib). This represents 0.3% of all adverse event reports for CELECOXIB.

80
Reports of Wrong technique in product usage process with CELECOXIB
0.3%
of all CELECOXIB reports
1
Deaths
3
Hospitalizations

How Dangerous Is Wrong technique in product usage process From CELECOXIB?

Of the 80 reports, 1 (1.3%) resulted in death, 3 (3.8%) required hospitalization.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CELECOXIB. However, 80 reports have been filed with the FAERS database.

What Other Side Effects Does CELECOXIB Cause?

Drug ineffective (8,188) Drug hypersensitivity (5,314) Pain (4,248) Rheumatoid arthritis (3,789) Off label use (3,782) Arthralgia (3,766) Nausea (3,497) Fatigue (3,235) Condition aggravated (3,060) Diarrhoea (3,017)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which CELECOXIB Alternatives Have Lower Wrong technique in product usage process Risk?

CELECOXIB vs CELIPROLOL CELECOXIB vs CELLCEPT CELECOXIB vs CEMIPLIMAB CELECOXIB vs CEMIPLIMAB-RWLC CELECOXIB vs CENEGERMIN-BKBJ

Related Pages

CELECOXIB Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process CELECOXIB Demographics